2. Commentary
children injured in motor vehicle accidents have a high rate of
permanent spinal cord lesions (25%).7 This study has increased Key points
awareness and contributed to the Ontario Ministry of Trans-
• Children and youth have the right to benefit from ethical
portation’s decision to mandate the use of booster seats. Advo-
health research
cacy efforts will continue until all provinces and territories adopt
• National case identification is necessary to answer research
both the use of proper child restraints in motor vehicles and questions about high-impact, low-frequency diseases
booster-seat legislation. • Surveillance provides valuable, timely epidemiological infor-
As one of the founding members of the International Net- mation for action
work of Paediatric Surveillance Units, which has 15 members • Governments have a duty to provide ongoing core funding
(Box 1), the Canadian Paediatric Surveillance Program offers to national surveillance pediatric research
the opportunity for international collaboration.8 Studies con-
ducted in more than one country allow for international com-
parison of diseases and conditions (e.g., hemorrhagic disease The Canadian Paediatric Surveillance Program is a versa-
of the newborn,9,10 congenital rubella syndrome,11 severe tile tool able to acquire timely epidemiological data and to
neonatal hyperbilirubinemia12) and other areas of public stimulate simultaneous collaborative research on diseases
health (e.g., hemolytic uremic syndrome13). Countries such and conditions that are associated with high disability, mor-
as Australia, Cyprus and Greece have initiated studies on bidity, mortality and economic cost to society. However, be-
vitamin D–deficiency rickets. Since these countries enjoy a cause the program is based on the voluntary participation of
much sunnier environment than Canada, comparison of the pediatricians and does not include family physicians, the re-
results from these studies with the Canadian data presented sulting incidence and prevalence rates are probably conser-
by Ward and colleagues will be most interesting. vative. Future challenges include maintaining high interest
The study by Ward and colleagues confirms the validity of and participation and continuing dissemination (in collabo-
the recommendations made by the Canadian Paediatric Society ration with the Canadian Paediatric Society) of results with
for vitamin D supplementation.14 It also demonstrates the need important medical and public health implications for use in
for heightened efforts by health care providers to ensure ade- policy development.
quate vitamin D intake for pregnant and lactating women and As illustrated by Ward and colleagues, children and youth
breast-fed infants. Epidemiological data also show the need for have the right to benefit from nationally funded epidemiologi-
educational materials aimed at the general public and for a re- cal research that can identify risk factors, monitor public health
view of prevention strategies that target high-risk groups. interventions, inform the development of new prevention
YT
100%
(2) NT
100%
(3) NU National initial
100% response rate: 82%
(1)
BC
81%
(249) AB
85% SK NL
(256) 69% MB 94% (46)
(46) 82%
(121)
ON QC
84% 78% PE
(938) (646) 100% (7)
NS
88% (87)
NB
87% (31)
Figure 1: Initial response rates (and number of participants) in the Canadian Paediatric Surveil-
lance Program in 2004.
170 CMAJ • July 17, 2007 • 177(2)
3. Commentary
Table 1: Studies performed by the Canadian Paediatric Surveillance Program that have had an important public health impact
Disease or condition Main finding Public health impact
Vitamin D–deficiency rickets • Over 100 children with vitamin D– • Supports the recommendation by the
deficiency rickets were identified, the Canadian Paediatric Society that children who
majority of whom were darker skinned and are exclusively breast-fed should receive
had been exclusively breast-fed vitamin D supplementation
Necrotizing fasciitis • Varicella was identified as the most • Supports the statement by the National
frequent risk factor among patients with Advisory Committee on Immunization on
group A streptococcal-related necrotizing universal childhood immunization against
fasciitis varicella
Lap-belt syndrome • 28 cases identified in a 2-year period; • Supports the advocacy by the Canadian
paraplegia developed in 25% of cases Paediatric Society that all provinces and
territories adopt the use of proper child
restraints in motor vehicles and booster-seat
legislation
Congenital rubella syndrome • Rare condition; 10 cases identified in a 10- • Supports the need to maintain universal as
year period, mostly in nonimmunized well as targeted immunizations
women
Acute flaccid paralysis • Active surveillance provided evidence of • Supports the obligation to report to the World
the elimination of poliovirus in Canada Health Organization polio eradication program
Subacute sclerosing • Rare condition; 2 cases identified in a 4- • Supports the need to maintain universal
panencephalitis year period immunization against measles and rubella
Hemorrhagic disease of the • Very low incidence: 0.22 per 100 000 live • Supports the Canadian Paediatric Society
newborn births statement that intramuscular vitamin K
injection is the “gold standard” for prevention
of hemorrhagic disease of the newborn
Neonatal herpes simplex virus • Estimated incidence of 5.9 cases per • Supports the need for a vaccine effective
(HSV) infection 100 000 live births; high mortality rate of against HSV-1 and HSV-2
15.5%
Neonatal severe • 258 cases confirmed over a 2-year period; • Supports the statement by the Canadian
hyperbilirubinemia estimated incidence rate of 1 in 2480 live Paediatric Society that newborns should be
births; 72% of the 258 cases were evaluated for risk factors of
readmitted at a mean age of 5 days hyperbilirubinemia and that bilirubin should
be measured before discharge
Head injury secondary to • Nearly 100 cases identified in a 21-month • Supports the need for more effective
suspected child maltreatment period; 70% had a suspected diagnosis of prevention efforts
(abuse or neglect) shaken baby syndrome
strategies and guide pediatric clinical practices. National sur- 7. Canadian Paediatric Surveillance Program. Booster seat use: Better safe than sorry!
Paediatr Child Health 2007;12:64. Available: www.pulsus.com/Paeds
veillance is an essential tool contributing to the improvement /12_01/Pdf/cpsp_ed.pdf (accessed 2007 June 19).
of the health and well-being of children and youth. 8. Elliott E, Nicoll A, Lynn R, et al. Rare disease surveillance: an international per-
spective. Paediatr Child Health 2001;6:251-60.
9. Canadian Paediatric Surveillance Program. Vitamin K injection — best prevention
Competing interests: None declared. for newborns. Paediatr Child Health 2002;7:588-9. Available: hwww.cps.ca/English
/surveillance/cpsp/publications/highlightspch.htm#2002 (accessed 2007 June 21).
10. McMillan DD, Grenier D, Medaglia A. Canadian Paediatric Surveillance Program
confirms low incidence of hemorrhagic disease of the newborn in Canada. Paedi-
REFERENCES atr Child Health 2004;9:235-8.
1. Ward LM, Gaboury I, Ladhani M, et al. Vitamin D–deficiency rickets among chil- 11. Canadian Paediatric Surveillance Program. Congenital rubella syndrome — time to
dren in Canada. CMAJ 2007;177:161-6. act on missed prevention opportunities. Paediatr Child Health 2003;8:107-8. Avail-
2. Office of the High Commissioner for Human Rights, United Nations. Convention able: www.cps.ca/English/surveillance/cpsp/publications/highlightspch.htm
on the rights of the child. Article 24. Geneva: The Office;1990. Available: www.un- #Congenital%20rubella%20syndrome (accessed 2007 June 21).
hchr.ch/html/menu3/b/k2crc.htm (accessed 2007 June 18). 12. Sgro M, Campbell D, Shah V. Incidence and causes of severe neonatal hyperbiliru-
3. World Health Organization (WHO). Making surveillance work. Geneva: WHO; binemia in Canada. CMAJ 2006;175:587-90.
2001. Available: www.who.int/vaccines-documents/DocsPDF01/www577.pdf (ac- 13. Grenier D, Elliott EJ, Zurynski Y, et al. Beyond counting cases: public health im-
cessed 2007 June 18) pacts of national Paediatric Surveillance Units. Arch Dis Child 2007;92:527-33.
4. US Centers for Disease Control and Prevention. Updated guidelines for evaluating 14. Godel J, First Nations and Inuit Health Committee. Vitamin D supplementation in
public health surveillance systems: recommendations from the Guidelines Work- northern Native communities. Paediatr Child Health 2002;7:459-63. Available:
ing Group. MMWR 2001;50(RR13):1-35. Available: www.cdc.gov/mmwr/pre- www.cps.ca/english/statements/II/ii02-02.htm (accessed 2007 June 19).
view/mmwrhtml/rr5013a1.htm (accessed 2007 June 18).
5. Canadian Paediatric Society. Canadian Paediatric Surveillance Program. Ottawa:
The Society; 2007. Available: www.cps.ca/english/surveillance/CPSP/index.htm
(accessed 2007 June 18). Correspondence to: Dr. Danielle Grenier, Medical Affairs Officer,
6. Eneli I, Davies HD. Epidemiology and outcome of necrotizing fasciitis (NF) in chil-
dren: a prospective surveillance study of the Canadian Paediatric Surveillance Pro- Canadian Paediatric Society, 2305 St. Laurent Blvd., Ottawa ON
gram. J Pediatr. In press. K1G 4J8; danielleg@cps.ca
CMAJ • July 17, 2007 • 177(2) 171